HCA Healthcare, Inc. $HCA Stock Holdings Lessened by Prosperity Consulting Group LLC

Prosperity Consulting Group LLC reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,496 shares of the company’s stock after selling 250 shares during the quarter. Prosperity Consulting Group LLC’s holdings in HCA Healthcare were worth $3,255,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Cheviot Value Management LLC acquired a new stake in HCA Healthcare during the 1st quarter valued at $26,000. Saudi Central Bank purchased a new position in shares of HCA Healthcare during the 1st quarter valued at $26,000. WPG Advisers LLC purchased a new position in shares of HCA Healthcare during the 1st quarter valued at $27,000. Ameriflex Group Inc. purchased a new position in shares of HCA Healthcare during the 2nd quarter valued at $27,000. Finally, Chung Wu Investment Group LLC purchased a new position in shares of HCA Healthcare during the 2nd quarter valued at $27,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

HCA has been the topic of a number of recent research reports. The Goldman Sachs Group lifted their target price on HCA Healthcare from $470.00 to $520.00 and gave the stock a “buy” rating in a research report on Monday, October 27th. Royal Bank Of Canada raised their price objective on shares of HCA Healthcare from $449.00 to $482.00 and gave the stock an “outperform” rating in a report on Monday, October 27th. Jefferies Financial Group raised their price objective on shares of HCA Healthcare from $485.00 to $525.00 and gave the stock a “buy” rating in a report on Tuesday, October 28th. Stephens raised their price objective on shares of HCA Healthcare from $450.00 to $500.00 and gave the stock an “overweight” rating in a report on Monday, October 27th. Finally, Robert W. Baird raised their price objective on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a report on Thursday, August 14th. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $473.53.

Insider Buying and Selling

In related news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $460.84 on Tuesday. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $478.19. The stock has a market cap of $107.83 billion, a PE ratio of 17.81, a PEG ratio of 1.38 and a beta of 1.40. The firm’s 50 day moving average price is $422.26 and its two-hundred day moving average price is $388.13.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same period last year, the firm earned $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s payout ratio is currently 11.13%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.